TLCV2-RB1
Plasmid
#87836
Purpose
LentiCRISPR v2 was modified into an all-in-one dox inducible system. The addition of doxycycline induces Cas9-2A-eGFP. The U6 promoter drives constitutive expression of an sgRNA targeting human RB1.
Depositor
Insert
sgRB1 (RB1 Human)
Use
CRISPR and Lentiviral; Doxycycline inducible; egf…
Expression
Mammalian
Promoter
Tight TRE promoter and U6
Available Since
April 12, 2017
Availability
Academic Institutions and Nonprofits only
